Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM229PE
TNBC
-
IKK16
IKK
NFKB
7535.1
uM
0.90842
1.74550
-0.9920 -1.0000 1.6821 0.6060
0.9931
0.8740
SUM229PE
TNBC
-
Imatinib
ABL/KIT/PDGFR
nRTK
7536.09
uM
5.28840
5.97590
-0.8266 -0.2285 3.0803 0.5234
0.7358
1.1257
SUM229PE
TNBC
-
Imatinib
ABL/KIT/PDGFR
nRTK
7535.092
uM
4.79920
11.29430
-0.9795 -1.0000 1.2837 0.6892
0.9769
1.1267
SUM229PE
TNBC
-
Imatinib
ABL/KIT/PDGFR
nRTK
7537.091
uM
22.32830
35.37410
-0.8881 -0.8842 2.2131 0.4003
0.9990
2.0227
SUM229PE
TNBC
-
Ispinesib
KSP
Kinesin
7537.067
uM
0.04217
0.43153
-0.8917 -1.0000 0.4724 0.6911
0.9357
1.9773
SUM229PE
TNBC
-
Ixabepilone
TUBB
TUBB
7537.095
uM
0.00129
0.16649
-0.8426 -1.0000 0.2259 0.9025
0.8089
1.9867
SUM229PE
TNBC
-
Ixabepilone
TUBB
TUBB
7535.095
uM
0.00741
0.02531
-0.9977 -0.8822 0.8277 1.0671
0.9688
0.8131
SUM229PE
TNBC
-
JNK-IN-5A
JNK
JNK
11058.144
uM
5.57780
0.74698
0.2152 0.3693 0.6674 0.2310
0.8560
2.1171
SUM229PE
TNBC
-
L-779450
BRAF
MAPK
11058.149
uM
29.3710
33.44390
0.2808 -0.4533 4.9690 0.0465
0.9754
2.1834
SUM229PE
TNBC
-
Lapatinib
EGFR/HER2
ErbB
7535.098
uM
inf
inf
0.8443 0.8443 0.0000 0.0793
-0.0135
1.0037
SUM229PE
TNBC
-
Lapatinib
EGFR/HER2
ErbB
7537.098
uM
20.68970
69.47480
0.5343 -0.3982 0.4836 0.1040
0.9689
1.8887
SUM229PE
TNBC
-
LBH589
HDAC
HDAC
11058.154
uM
0.34314
0.57547
-0.6155 -0.5953 1.5166 0.4957
0.9965
2.0897
SUM229PE
TNBC
-
Lestaurtinib
FLT3/JAK2/TrkA
RTK
11058.154
uM
0.45129
1.84470
-0.5592 -0.7539 0.6530 0.4208
0.9917
2.0897
SUM229PE
TNBC
-
Mebendazole
13062.174
uM
21.85180
649.20950
0.2977 -1.0000 0.3239 0.1848
0.9092
1.6688
SUM229PE
TNBC
-
Mebendazole
13009.174
uM
0.27704
0.26351
-0.0137 0.0324 1.3375 0.4514
0.9639
1.4104
SUM229PE
TNBC
-
Methotrexate
DHFR
Metabolism
7537.084
uM
inf
0.14909
0.6713 0.6999 4.9991 0.1845
0.9423
1.8684
SUM229PE
TNBC
-
Methylglyoxal
13062.184
uM
489.42160
1000.00000
-0.8881 -0.8545 1.3948 0.6065
0.9903
1.7868
SUM229PE
TNBC
-
Methylglyoxal
13201.184
uM
535.45630
662.02810
-0.9518 -0.9445 4.9999 0.6502
0.9991
1.3314
SUM229PE
TNBC
-
MG-132
Proteasome
Proteasome
14224.189
uM
0.15754
0.16136
-0.4163 -0.0638 5.0000 0.5693
0.5763
1.8849
SUM229PE
TNBC
-
MG-132
Proteasome
Proteasome
14224.189
uM
0.15754
0.16136
-0.4163 -0.0638 5.0000 0.5693
0.5763
1.8849
SUM229PE
TNBC
-
MG-132
Proteasome
Proteasome
11058.145
uM
0.11057
0.14934
-0.6137 -0.5960 2.6106 0.7457
0.9989
2.2039
SUM229PE
TNBC
-
MG-132
Proteasome
Proteasome
11058.145
uM
0.11057
0.14934
-0.6137 -0.5960 2.6106 0.7457
0.9989
2.2039
SUM229PE
TNBC
-
Pevonedistat
NAE1
NAE1
11058.135
uM
0.29089
0.27058
-0.0109 0.0494 1.4364 0.4085
0.9879
2.1492
SUM229PE
TNBC
-
Nelfinavir
13062.174
uM
inf
inf
0.8787 0.8787 0.0000 0.0341
0.4048
1.6688
SUM229PE
TNBC
-
Nelfinavir
13009.174
uM
6.26470
9.98760
-0.8378 -0.9544 2.2893 0.2181
0.9953
1.4104